Reposted by Andrew Lynch
MD Anderson’s sarcoma team has received a $1.8M SPORE grant from the NCI to advance new immunologic and targeted sarcoma treatments.
The work includes a trial of adoptive cellular therapy for chordoma and a trial of antibody-drug conjugates for osteosarcoma.
#OncSky #EndCancer